ECSP992858A - Anticuerpos contra cd40 humano - Google Patents
Anticuerpos contra cd40 humanoInfo
- Publication number
- ECSP992858A ECSP992858A ECSP992858A ECSP992858A EC SP992858 A ECSP992858 A EC SP992858A EC SP992858 A ECSP992858 A EC SP992858A EC SP992858 A ECSP992858 A EC SP992858A
- Authority
- EC
- Ecuador
- Prior art keywords
- antibodies
- antibodies against
- against human
- human
- applicants
- Prior art date
Links
- 101150013553 CD40 gene Proteins 0.000 title abstract 4
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 title abstract 4
- 102100032937 CD40 ligand Human genes 0.000 abstract 1
- 101000759376 Escherichia phage Mu Tail sheath protein Proteins 0.000 abstract 1
- 101000868215 Homo sapiens CD40 ligand Proteins 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 230000028996 humoral immune response Effects 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Los solicitantes han descubierto nuevos anticuerpos CD40 anti-humanos quiméricos y humanizados que bloquean la interacción entre gp39 y CD40. Los anticuerpos CD40 de la presente invención son efectivos en la modulación de respuestas inmunes humorales contra antígenos que dependen de la célula T, artritis introducida por colágeno, y transplante de piel, y también son útiles por sus propiedades anti-inflamatorias.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP992858 ECSP992858A (es) | 1999-02-12 | 1999-02-12 | Anticuerpos contra cd40 humano |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP992858 ECSP992858A (es) | 1999-02-12 | 1999-02-12 | Anticuerpos contra cd40 humano |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP992858A true ECSP992858A (es) | 2000-09-22 |
Family
ID=42043847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP992858 ECSP992858A (es) | 1999-02-12 | 1999-02-12 | Anticuerpos contra cd40 humano |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP992858A (es) |
-
1999
- 1999-02-12 EC ECSP992858 patent/ECSP992858A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9908045A (pt) | Anticorpos contra cd40 humano | |
| IN2012DN00313A (es) | ||
| MX2009008918A (es) | Activacion de celulas que presentan antigeno humano a traves de clec-6. | |
| UY28424A1 (es) | Anticuerpos rgi y usos de los mismos. | |
| CY1107802T1 (el) | Συνθεσεις και μεθοδοι για επαγωγη ειδικων κυτταρολυτικων αποκρισεων t-λεμφοκυτταρων | |
| MY150237A (en) | Cripto blocking antibodies and uses thereof | |
| WO2005037190A3 (en) | Multiplex vaccines | |
| CR9562A (es) | Anticuerpos anti-cd40 humanizados y sus metodos de uso | |
| PT699237E (pt) | Fvs de cadeia anti-egfr e anticorpos anti-egfr | |
| EP0671927A4 (en) | HUMAN, NEUTRALIZING, MONOCLONAL ANTIBODIES AGAINST THE RESPIRATORY SYNCYTIAL VIRU. | |
| ECSP045470A (es) | Productos biologicos | |
| HUP0400951A2 (hu) | Egy tumornekrózis faktorral rokon apoptózis indikáló ligandum receptorára specifikus antitest és alkalmazásai | |
| DE60141964D1 (de) | Bandscheibe | |
| FR12C0004I1 (es) | ||
| YU28503A (sh) | Humanizovana anti-lt-beta-r antitela | |
| IL172854A0 (en) | Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations | |
| TR200102034T2 (tr) | Anti kanser aşılaması için antikorların kullanılması | |
| MX2022013393A (es) | Receptores de antígenos quiméricos dirigidos a cd19 y uso de los mismos. | |
| NO965395L (no) | Humane, monoklonale antistoffer som er spesifikke mot cellecyklus-uavhengig gliom-overflateantigen | |
| TW200640947A (en) | Novel polypeptide ligands for toll-like receptor 2 (TLR2) | |
| WO2020172482A3 (en) | Cd80 extracellular domain-fc fusion proteins for treating pd-l1 negative tumors | |
| Lund et al. | Signal sequence deletion and fusion to tetanus toxoid epitope augment antitumor immune responses to a human carcinoembryonic antigen (CEA) plasmid DNA vaccine in a murine test system | |
| DK1000163T3 (da) | Pseudomonas-exotoksin A-lignende kimære immunogener | |
| UA94211C2 (ru) | Выделенное полностью человеческое моноклональное cd3 антитело | |
| ECSP992858A (es) | Anticuerpos contra cd40 humano |